Literature DB >> 20962202

Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle.

J L Gamboa1, Mary L Garcia-Cazarin, Francisco H Andrade.   

Abstract

People living at high altitude appear to have lower blood glucose levels and decreased incidence of diabetes. Faster glucose uptake and increased insulin sensitivity are likely explanations for these findings: skeletal muscle is the largest glucose sink in the body, and its adaptation to the hypoxia of altitude may influence glucose uptake and insulin sensitivity. This study tested the hypothesis that chronic normobaric hypoxia increases insulin-stimulated glucose uptake in soleus muscles and decreases plasma glucose levels. Adult male C57BL/6J mice were kept in normoxia [fraction of inspired O₂ = 21% (Control)] or normobaric hypoxia [fraction of inspired O₂ = 10% (Hypoxia)] for 4 wk. Then blood glucose and insulin levels, in vitro muscle glucose uptake, and indexes of insulin signaling were measured. Chronic hypoxia lowered blood glucose and plasma insulin [glucose: 14.3 ± 0.65 mM in Control vs. 9.9 ± 0.83 mM in Hypoxia (P < 0.001); insulin: 1.2 ± 0.2 ng/ml in Control vs. 0.7 ± 0.1 ng/ml in Hypoxia (P < 0.05)] and increased insulin sensitivity determined by homeostatic model assessment 2 [21.5 ± 3.8 in Control vs. 39.3 ± 5.7 in Hypoxia (P < 0.03)]. There was no significant difference in basal glucose uptake in vitro in soleus muscle (1.59 ± 0.24 and 1.71 ± 0.15 μmol·g⁻¹·h⁻¹ in Control and Hypoxia, respectively). However, insulin-stimulated glucose uptake was 30% higher in the soleus after 4 wk of hypoxia than Control (6.24 ± 0.23 vs. 4.87 ± 0.37 μmol·g⁻¹·h⁻¹, P < 0.02). Muscle glycogen content was not significantly different between the two groups. Levels of glucose transporters 4 and 1, phosphoinositide 3-kinase, glycogen synthase kinase 3, protein kinase B/Akt, and AMP-activated protein kinase were not affected by chronic hypoxia. Akt phosphorylation following insulin stimulation in soleus muscle was significantly (25%) higher in Hypoxia than Control (P < 0.05). Neither glycogen synthase kinase 3 nor AMP-activated protein kinase phosphorylation changed after 4 wk of hypoxia. These results demonstrate that the adaptation of skeletal muscles to chronic hypoxia includes increased insulin-stimulated glucose uptake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962202      PMCID: PMC3023279          DOI: 10.1152/ajpregu.00078.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  37 in total

1.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle.

Authors:  J Mu; J T Brozinick; O Valladares; M Bucan; M J Birnbaum
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

2.  Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians.

Authors:  Folke Lindgärde; Miyaray Benavente Ercilla; Laura Retamozo Correa; Bo Ahrén
Journal:  High Alt Med Biol       Date:  2004       Impact factor: 1.981

3.  Metabolic and work efficiencies during exercise in Andean natives.

Authors:  P W Hochachka; C Stanley; G O Matheson; D C McKenzie; P S Allen; W S Parkhouse
Journal:  J Appl Physiol (1985)       Date:  1991-04

4.  Oxidative phosphorylation of liver mitochondria from mice acclimatized to hypobaric hypoxia.

Authors:  F Leon-Velarde; J Whittembury; C Monge
Journal:  Int J Biometeorol       Date:  1986-09       Impact factor: 3.787

5.  Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation.

Authors:  Jonathan S Fisher; Lorraine A Nolte; Kentaro Kawanaka; Dong-Ho Han; Terry E Jones; John O Holloszy
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-06       Impact factor: 4.310

6.  Sparing effect of chronic high-altitude exposure on muscle glycogen utilization.

Authors:  A J Young; W J Evans; A Cymerman; K B Pandolf; J J Knapik; J T Maher
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-04

7.  Energetic metabolism in mouse cerebral cortex during chronic hypoxia.

Authors:  R Cáceda; J L Gamboa; J A Boero; C Monge-C; A Arregui
Journal:  Neurosci Lett       Date:  2001-04-06       Impact factor: 3.046

8.  Increased dependence on blood glucose after acclimatization to 4,300 m.

Authors:  G A Brooks; G E Butterfield; R R Wolfe; B M Groves; R S Mazzeo; J R Sutton; E E Wolfel; J T Reeves
Journal:  J Appl Physiol (1985)       Date:  1991-02

9.  Intermittent hypoxia increases insulin resistance in genetically obese mice.

Authors:  Vsevolod Y Polotsky; Jianguo Li; Naresh M Punjabi; Arnon E Rubin; Philip L Smith; Alan R Schwartz; Christopher P O'Donnell
Journal:  J Physiol       Date:  2003-07-23       Impact factor: 5.182

Review 10.  Unravelling the activation mechanisms of protein kinase B/Akt.

Authors:  Michael P Scheid; James R Woodgett
Journal:  FEBS Lett       Date:  2003-07-03       Impact factor: 4.124

View more
  24 in total

1.  Intermittent hypoxia maintains glycemia in streptozotocin-induced diabetic rats.

Authors:  Xiaofei Chen; Tong Zhao; Xin Huang; Liying Wu; Kuiwu Wu; Ming Fan; Lingling Zhu
Journal:  Cell Stress Chaperones       Date:  2016-02-22       Impact factor: 3.667

2.  Acclimation to hypoxia increases carbohydrate use during exercise in high-altitude deer mice.

Authors:  Daphne S Lau; Alex D Connaty; Sajeni Mahalingam; Nastashya Wall; Zachary A Cheviron; Jay F Storz; Graham R Scott; Grant B McClelland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-11       Impact factor: 3.619

3.  Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia.

Authors:  Euhan J Lee; Laura C Alonso; Darko Stefanovski; Hilary C Strollo; Lia C Romano; Baobo Zou; Srikanth Singamsetty; Keith A Yester; Kenneth R McGaffin; Adolfo Garcia-Ocana; Christopher P O'Donnell
Journal:  Eur J Appl Physiol       Date:  2012-07-17       Impact factor: 3.078

Review 4.  HIF-1-driven skeletal muscle adaptations to chronic hypoxia: molecular insights into muscle physiology.

Authors:  F B Favier; F A Britto; D G Freyssenet; X A Bigard; H Benoit
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

Review 5.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

6.  The prevalence of obesity and metabolic syndrome in Tibetan immigrants living in high altitude areas in Ladakh, India.

Authors:  Belle Yanyu Lin; Karma Genden; Wei Shen; Po-Shu Wu; Wen-Chien Yang; Hui-Fang Hung; Chun-Min Fu; Kuen-Cheh Yang
Journal:  Obes Res Clin Pract       Date:  2017-04-12       Impact factor: 2.288

Review 7.  Glucose homeostasis during short-term and prolonged exposure to high altitudes.

Authors:  Orison O Woolcott; Marilyn Ader; Richard N Bergman
Journal:  Endocr Rev       Date:  2015-02-12       Impact factor: 19.871

8.  Acute systemic insulin intolerance does not alter the response of the Akt/GSK-3 pathway to environmental hypoxia in human skeletal muscle.

Authors:  Gommaar D'Hulst; Lykke Sylow; Peter Hespel; Louise Deldicque
Journal:  Eur J Appl Physiol       Date:  2015-01-11       Impact factor: 3.078

9.  Regulation of a truncated isoform of AMP-activated protein kinase α (AMPKα) in response to hypoxia in the muscle of Pacific oyster Crassostrea gigas.

Authors:  Eric Guévélou; Arnaud Huvet; Rossana Sussarellu; Massimo Milan; Ximing Guo; Li Li; Guofan Zhang; Virgile Quillien; Jean-Yves Daniel; Claudie Quéré; Pierre Boudry; Charlotte Corporeau
Journal:  J Comp Physiol B       Date:  2013-01-25       Impact factor: 2.200

10.  The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells.

Authors:  Britta Kunkemoeller; Kuangyang Chen; Sam M Lockhart; Xuanchun Wang; Christian Rask-Madsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-06-21       Impact factor: 5.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.